Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023.
Metabolic energy sensors as targets for designing host-directed therapies for tuberculosis.
Use of medications of questionable benefit in advanced dementia.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Use of medications of questionable benefit in advanced dementia.
Tjia J, Briesacher BA, Peterson D, Liu Q, Andrade SE, Mitchell SL. Use of medications of questionable benefit in advanced dementia. JAMA Intern Med. 2014 Nov; 174(11):1763-71.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Cross-Sectional Studies
Dementia
Female
Health Services Misuse
Humans
Inappropriate Prescribing
Male
Nursing Homes
Terminal Care
authors with profiles
Jennifer Tjia MD, MSCE